Blocking new protein synthesis with cycloheximide strongly reduced CCN6 protein levels in 4T1 mouse breast cancer cells (Figure 1A and Figure S1), indicating that CCN6 protein levels are tightly regulated by protein degradation. Here, CCN6 is linked to breast cancer.